Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China
BackgroundThe 2021 Chinese Expert Consensus on the Clinical Application of the Human Papillomavirus (HPV) Vaccine recommended vaccination for women who previously received ablative or excisional treatment for high-grade squamous intraepithelial lesion (HSIL). This study evaluates the cost-effectiven...
Main Authors: | Maosheng Zou, Hanting Liu, Huan Liu, Mengjie Wang, Zhuoru Zou, Lei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1119566/full |
Similar Items
-
Potential of trichloroacetic acid (TCA) for cervical precancerous lesions treatment in Indonesia
by: I Gde Sastra Winata, et al.
Published: (2022-04-01) -
Efficacy and Safety of Thermocoagulation vs. Cryotherapy for Cervical Precancerous Lesions: A Systematic Review and Meta-Analysis
by: Jie Liu, et al.
Published: (2024-03-01) -
Cervical Cancer Awareness and Detection of Precancerous Lesions at Two District Health Centres in the West Region of Cameroon
by: Richard Tagne Simo, et al.
Published: (2021-07-01) -
Cervical Precancerous Lesion Image Enhancement Based on Retinex and Histogram Equalization
by: Yuan Ren, et al.
Published: (2023-08-01) -
Prevalence of Precancerous Cervical Lesions among Nonvaccinated Kazakhstani Women: The National Tertiary Care Hospital Screening Data (2018)
by: Balkenzhe Imankulova, et al.
Published: (2023-01-01)